MATOS Masters in Thoracic Oncology Summit 2023

Name: MATOS Masters in Thoracic Oncology Summit 2023
SKU: MED-AMB07006
Price: 20.00 USD
Availability: InStock

$20.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Recommended medical resources for your specialty.

MATOS Masters in Thoracic Oncology Summit 2023

$20.00

Memorial Sloan Kettering Cancer Center Radiologic Interpretation in the Oncology Population 2026

1 × Memorial Sloan Kettering Cancer Center Radiologic Interpretation in the Oncology Population 2026

$30.00

Cleveland Clinic 38th Annual Intensive Review of Internal Medicine 2026

1 × Cleveland Clinic 38th Annual Intensive Review of Internal Medicine 2026

$75.00

USCAP Confronting the Unfamiliar and Unnerving in Dermpath Practical Tips to Curb Hair Pulling and Nail Biting at the Microscope 2026

1 × USCAP Confronting the Unfamiliar and Unnerving in Dermpath Practical Tips to Curb Hair Pulling and Nail Biting at the Microscope 2026

$130.00

Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th Edition (Original PDF from Publisher)

1 × Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th Edition (Original PDF from Publisher)

$15.00

Carefully selected courses and references to support your clinical practice.

SKU: MED-AMB07006 Categories: Hematology / Oncology, Pathology, Radiology, Respiratory / Pulmonary Tag: synced-from-medu

Description

MATOS Masters in Thoracic Oncology Summit 2023 (Videos)

Comprehensive Lung Cancer, Thoracic Malignancies, Targeted Therapy & Immunotherapy Summit

The MATOS Masters in Thoracic Oncology Summit 2023 is a specialized oncology conference focused on the rapidly evolving field of thoracic malignancies, bringing together internationally recognized experts to discuss the latest advances in lung cancer diagnosis, molecular profiling, targeted therapies, immunotherapy, minimal residual disease (MRD), and precision oncology.

Organized by Meetings Events & Conference Coordinators (MECC), this summit provides a multidisciplinary educational platform designed to improve patient outcomes through the integration of cutting-edge research, innovative treatment strategies, and emerging diagnostic technologies in thoracic oncology.

Package Includes

52 Video Lectures
Total Size: 4.51 GB
Expert Faculty Presentations
Thoracic Oncology Updates
Precision Medicine Education
Molecular Oncology Reviews
Clinical Case Discussions
Evidence-Based Treatment Strategies

Overview

Thoracic oncology continues to undergo rapid transformation due to advances in molecular diagnostics, biomarker-driven therapies, immunotherapy, and personalized treatment approaches. The MATOS Masters in Thoracic Oncology Summit 2023 addresses these developments by providing comprehensive reviews of current standards of care and emerging innovations in lung cancer management.

The program focuses on translating scientific discoveries into clinical practice, helping clinicians navigate increasingly complex treatment decisions while optimizing outcomes for patients with thoracic malignancies.

Learning Objectives

Upon completion of this activity, participants should be able to:

Apply contemporary treatment strategies for thoracic malignancies.
Interpret molecular and genetic testing results in lung cancer patients.
Utilize biomarker-driven approaches to guide therapy selection.
Evaluate the role of immunotherapy in thoracic oncology.
Understand the clinical applications of minimal residual disease monitoring.
Integrate emerging targeted therapies into treatment plans.
Assess strategies for recurrence monitoring and disease surveillance.
Improve multidisciplinary management of patients with lung cancer.

Topics Covered

Lung Cancer Management

Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Early-Stage Lung Cancer
Advanced Thoracic Malignancies
Multidisciplinary Treatment Planning

Molecular Oncology

Molecular Profiling
Precision Medicine
Driver Mutations
Biomarker Testing
Genomic Alterations

Genetics & Epigenomics

Cancer Genetics
Epigenetic Mechanisms
Personalized Oncology
Emerging Molecular Targets
Translational Research

Targeted Therapy

EGFR-Targeted Therapies
ALK Inhibitors
ROS1 Inhibitors
KRAS-Targeted Treatments
Novel Molecular Agents

Immunotherapy

Immune Checkpoint Inhibitors
PD-1/PD-L1 Therapies
Combination Immunotherapy
Treatment Selection Strategies
Immunotherapy Resistance

Minimal Residual Disease (MRD)

MRD Detection Technologies
Liquid Biopsy Applications
Disease Monitoring
Early Recurrence Detection
Precision Surveillance

Recurrence Monitoring

Post-Treatment Surveillance
Imaging Strategies
Biomarker Monitoring
Disease Progression Assessment

Thoracic Imaging

Diagnostic Imaging
Staging Evaluation
Response Assessment
Radiologic Monitoring

Surgical Oncology

Thoracic Surgery
Surgical Decision-Making
Multimodal Treatment Approaches
Postoperative Management

Radiation Oncology

Stereotactic Body Radiation Therapy (SBRT)
Definitive Radiation Therapy
Combined-Modality Treatment
Emerging Radiation Techniques

Target Audience

This course is ideal for:

Medical Oncologists
Radiation Oncologists
Thoracic Surgeons
Pulmonologists
Radiologists
Pathologists
Oncology Fellows
Oncology Nurses
Nurse Practitioners
Clinical Researchers
Translational Scientists

Why This Course Stands Out

✔ Comprehensive Thoracic Oncology Review

✔ Focus on Precision Medicine

✔ Advanced Immunotherapy Education

✔ Molecular Oncology Updates

✔ MRD and Liquid Biopsy Applications

✔ Biomarker-Driven Treatment Strategies

✔ Multidisciplinary Faculty Perspectives

✔ Lung Cancer Research Insights

✔ Clinical and Translational Oncology Integration

✔ Practical Applications for Modern Cancer Care

Topics:

ALK in Front Line Therapy Second or Third Generation TKI Inhibitors What Can Help Us to Choose the Best Therapeutic Agent.mp4
Anti-CEACAM and ROR ADCs.mp4
Best Approaches for First Line EGFRm NSCLC.mp4
Best Surgical Approaches for Stage III NSCLC.mp4
Biomarkers for Perioperative Immunotherapy.mp4
Brain Radiotherapy in Small Cell Lung Cancer When.mp4
Cellular Therapies in NSCLC Is it feasible.mp4
ctDNA Analyses in Early Detection Methylation, Proteomics and Other Efforts for Early Lung Cancer Detection.mp4
Deciphering the Mechanism of Resistance to First Generation KRAS Inhibitors.mp4
Developing New Anti-CTL4s for NSCLC Is There Any Role.mp4
Early Stage Resectable Lung Cancer Adjuvant Immunotherapy.mp4
Exon 20 and Uncommon EGFR Sensitive Mutations.mp4
Frontline What are We Adding to Checkpoint Inhibitors and Chemotherapy.mp4
Future Challenges for lmmunotherapy in the Fight Against NSCLC.mp4
Health Care Disparities in Lung Cancer Genomic Profiling Has Precision Oncology Widened the Gap.mp4
HER-3 as a New Target in NSCLC.mp4
HER2 Tx in Advanced NSCLC From TKls to ADCs.mp4
How to Rescue Patients from Osimertinib Resistance.mp4
How to Start a Lung Cancer Screening Program.mp4
Improving Targeted Therapies for Patients with Lung Cancers Where are the gaps and ways to fill them.mp4
KRAS mutant NSCLC What is the Standard of Care Now.mp4
Lack of Equity in Clinical Outcomes in Blacks and Hispanics with NSCLC.mp4
Limited Stage SCLC 2023.mp4
Management of LA-NSCLC in Pts with PD-L1 – 1% or Oncogenic Drivers.mp4
Mechanisms of Resistance to ALK Inhibitors.mp4
Minimal Residual Disease as Detected by Liquid Biopsy Where are We Going.mp4
MRD to Decide Perioperative Management in the Era of Immuno-Oncology.mp4
Neoadjuvant Immunotherapy Position.mp4
Novel Therapies for Thymic Malignancies.mp4
NRG1 as a Target in NSCLC.mp4
Optimal Management of Extensive SCLC (1st and 2nd Line).mp4
Overcoming T-Cell Exhaustion.mp4
Pan-KRAS Inhibitors Where are We Going.mp4
PARP Inhibitors in SCLC.mp4
Predictive Biomarkers in Small Cell Lung Carcinoma.mp4
Radiation Induced Immune Responses in NSCLC.mp4
RET and NTRK The Good, The Bad, The Ugly…. and What’s Coming Up.mp4
Role of Interleukins to Improve Efficacy of Immunotherapy.mp4
Role of Radiotherapy in TIME Good Bad Don’t know.mp4
ROS1 and BRAf Inhibitors New Developments.mp4
Stage III Non-Surgical NSCLC Optimal Radiation Therapy Treatment Approach.mp4
Strategies to Target Minimal Residual Disease in Lung Cancer.mp4
Surgery for Malignant Pleural Mesothelioma.mp4
Systemic Therapies for Mesothelioma.mp4
The Importance of TIME in Cancer Treatment How to Target It.mp4
The New Role of Microbiome in Lung Cancer Immunotherapy.mp4
The Role of Co-Mutations in Immunotherapy Response in NSCLC.mp4
The Role of SHP-2 Inhibitors Alone or in Combination.mp4
TROP-2 and AXL as Targets in NSCLC.mp4
Updates in Bispecific Antibodies in NSCLC.mp4
What Comes After Immunotherapy Failure in Terms of More Immunomodulation.mp4
What’s After PACIFIC Can We Raise the Bar.mp4

You can Pay crypto Get discount Contact US

You can Pay crypto Get discount Contact US

MATOS Masters in Thoracic Oncology Summit 2023

MATOS Masters in Thoracic Oncology Summit 2023 (Videos)

Package Includes

Overview

Learning Objectives